The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1995-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9378(95)90365-8PMID 7573268
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

  1994cited by this paper
• Pharmacokinetic properties of the tocolytic agent [Mpa1d‐Tyr(Et)2, Thr4, Orn8]‐oxytocin (antocin) in healthy volunteers

  1993cited by this paper
• Oxytocin receptor blockade: a new principle in the treatment of preterm labor?

  1989cited by this paper
• Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study

  1988cited by this paper
• Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study

  1987cited by this paper
• Evaluation of 1-deamino-[D-Tyr(Oethyl)2, Thr4, Orn8] vasotocin, an oxytocin antagonist, in animal models of uterine contractility and preterm labor: a new tocolytic agent.

  1987cited by this paper
• Synthetic antagonists of the myometrial response to vasopressin and oxytocin.

  1986cited by this paper
• Pharmacokinetics in the human of a new synthetic vasopressin and oxytocin uterine antagonist.

  1986cited by this paper

• Atosiban in individuals with previous implantation failure undergoing frozen blastocyst transfer: a randomized controlled trial.

  2025cites this paper
• The biased OTR ligands -atosiban and carbetocin- differentially inhibit early or late formalin-induced nociception in rats.

  2025cites this paper
• Recurrence quantification analysis of uterine vectormyometriogram to identify pregnant women with threatened preterm labor

  2024cites this paper
• The oxytocin antagonist cligosiban reduces human prostate contractility: Implications for the treatment of benign prostatic hyperplasia

  2024influential citation
• Effectiveness of atosiban in women with previous single implantation failure undergoing frozen-thawed blastocyst transfer: study protocol for a randomised controlled trial

  2023cites this paper
• Effects of oxytocin and antagonist antidote atosiban on body weight and food intake of female mice, Mus musculus

  2021cites this paper
• A novel HPLC method for analysis of atosiban and its five related substances in atosiban acetate injection.

  2020cites this paper
• Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone

  2019cites this paper
• The Effect of Atosiban on Patients With Difficult Embryo Transfers Undergoing In Vitro Fertilization–Embryo Transfer

  2019cites this paper
• Characterization of the effects of Atosiban on uterine electromyograms recorded in women with threatened preterm labor

  2019cites this paper
• Effect of Intravenous Treatment with the Oxytocin Antagonist Atosiban on Circulating Progesterone in the Ewe

  2019cites this paper
• Bryophyllum pinnatum enhances the inhibitory effect of atosiban and nifedipine on human myometrial contractility: an in vitro study

  2019cites this paper
• FOGSI FOCUS Emerging Trends in Infertility

  2019cites this paper
• Safety and Efficacy of Tocolytics for the Treatment of Spontaneous Preterm Labour.

  2019cites this paper
• Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application.

  2018cites this paper
• Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury

  2018cites this paper
• Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development

  2018cites this paper
• Effect of tocolytic drugs on fetal heart rate variability: a systematic review

  2017cites this paper
• The prospects of fetal electrocardiography during pregnancy and labour

  2017cites this paper
• Is a cause of postpartum hemorrhage of using of tocolytic agents in preterm delivery?

  2017cites this paper
• A patent review of oxytocin receptor antagonists 2013-2017

  2017cites this paper
• Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review

  2016cites this paper
• Fetal fibronectin in the prediction of preterm birth

  2016cites this paper
• Which Factors Contribute to False-Positive, False-Negative, and Invalid Results in Fetal Fibronectin Testing in Women with Symptoms of Preterm Labor?

  2016cites this paper
• Involvement of the oxytocin system in the bed nucleus of the stria terminalis in the sex-specific regulation of social recognition.

  2016cites this paper
• Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?

  2015cites this paper
• Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days

  2015cites this paper
• Comparison of oral nifedipine and transdermal nitroglycerine as a tocolytic for preterm labour

  2015cites this paper
• Randomized Comparison of Nifedipine and Placebo in Fibronectin-Negative Women with Symptoms of Preterm Labor and a Short Cervix (APOSTEL-I Trial)

  2014cites this paper
• Obstetric Drugs in the Management of Cardiovascular Disease

  2014cites this paper
• Atosiban Versus Nifedipin for the Management of Preterm Labor : A Prospective Study

  2014cites this paper
• Atosiban for Preterm Labour

  2012cites this paper
• Tocolytic therapy for acute preterm labor.

  2012cites this paper
• Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction.

  2011cites this paper
• Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: a retrospective study.

  2011cites this paper
• The influence of tocolytic drugs on cardiac function, large arteries, and resistance vessels

  2011cites this paper
• Oxytocin antagonists for the management of preterm birth: a review.

  2011cites this paper
• Oxytocin Antagonists for the Management of Preterm Birth: A Review

  2010cites this paper
• Different effects of tocolytic medication on blood pressure and blood pressure amplification

  2010cites this paper
• Critical appraisal and clinical utility of atosiban in the management of preterm labor

  2010cites this paper
• Evaluation of efficacy of transdermal Nitroglycerine in the treatment of preterm labour

  2010cites this paper
• Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF.

  2010cites this paper
• Preterm Labor and Delivery

  2009cites this paper
• Atosiban as a tocolytic for the treatment of spontaneous preterm labor

  2008cites this paper
• Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.

  2008cites this paper
• Oxytocin is not important for the control of gonadotrophin secretion in the late follicular phase of the cycle

  2007cites this paper
• Effect of atosiban on rabbit embryo development and human sperm motility.

  2007cites this paper
• Oxytocin antagonists may improve infertility treatment.

  2007cites this paper
• Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers

  2006cites this paper
• The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human

  2006cites this paper
• Atosiban's effect in the extracorporeal perfused swine uterus.

  2006cites this paper
• Atosiban and nifedipin for the treatment of preterm labor

  2005cites this paper
• A Comparison between the Effect of Atosiban (Oxytocin Antagonist) Versus Nifedipine(Ca Channel Blocker) for Preterm Labor Control and the Related Complications

  2005cites this paper
• Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers

  2005influential citation
• GPCR agonists and antagonists in the clinic.

  2005cites this paper
• Treatment of Labour Contractions and Pain - Effects on Foetal Well-being and Uterine Contractility Monitored by Cardiotocography

  2005cites this paper
• Recent pharmacological advances in the treatment of preterm membrane rupture, labour and delivery

  2004influential citation
• Preterm labour: an overview of current and emerging therapeutics.

  2003cites this paper
• Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats

  2003cites this paper
• Evidence that oxytocin is a physiological component of LH regulation in non-pregnant women.

  2003cites this paper
• Comparison of Oxytocin and Oxytocin Antagonist Metabolism in the Plasma of Pregnant Humans and Baboons

  2002cites this paper
• Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats

  2002cites this paper
• Clarithromycin inhibits myometrial contractions in isolated human myometrium independent of stimulus.

  2002cites this paper
• Atosiban: Perspectives On The Etiological Management of Preterm Labor

  2002cites this paper
• ATOSIBAN, PERSPECTIVAS SOBRE EL MANEJO ETIOLOGICO DEL PARTO PREMATURO

  2002cites this paper
• Effects of Oxytocin Receptor Antagonist Atosiban on Pregnant Myometrium In Vitro

  2001cites this paper
• Oxytocin Antagonists: Clinical and Scientific Considerations

  2001cites this paper
• Inhibition of Prostaglandin Synthesis and Its Effect on Uterine Activity During Established Premature Labor in Sheep

  2001cites this paper
• The oxytocin antagonist atosiban versus the β‐agonist terbutaline in the treatment of preterm labor

  2001cites this paper
• Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.

  2001cites this paper
• The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.

  2001cites this paper
• The contemporary use of tocolytics

  2000cites this paper
• An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.

  2000cites this paper
• Atosiban, an oxytocin receptor blocking agent: pharmacokinetics and inhibition of milk ejection in dairy cows

  1999cites this paper
• A Risk-Benefit Assessment of Therapies for Premature Labour

  1999cites this paper
• Central Hemodynamic Effects of an Oxytocin Receptor Antagonist (Atosiban) in the Isolated, Perfused Rat Heart

  1999cites this paper
• Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban

  1998cites this paper
• Current perspectives on drug treatment for preterm labour.

  1998cites this paper
• [Tocolytic agents].

  1998cites this paper
• Oxytocin receptor antagonists. Update.

  1998cites this paper
• Preterm birth in the United States: current issues and future perspectives.

  1997cites this paper
• PRETERM LABOR AND PRETERM PREMATURE RUPTURE OF THE MEMBRANES Diagnosis and Management

  1997cites this paper
• Oxytocin in the human--regulation of derivations and destinations.

  1997cites this paper
• Preterm labor and preterm premature rupture of the membranes. Diagnosis and management.

  1997cites this paper
• Central hemodynamic effects of oxytocin and interaction with magnesium and pregnancy in the isolated perfused rat heart.

  1997cites this paper
• Dose Ranging Study of the Oxytocin Antagonist Atosiban in the Treatment of Preterm Labor

  1996cites this paper
• Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.

  1996cites this paper